Glecaprevir–pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies—a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2)-Reference-Cited by-同舟云学术

Glecaprevir–pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies—a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2)

Published:2020-09 Issue:9 Volume:5 Page:839-849
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Wei Lai,Wang Guiqiang,Alami Negar N,Xie Wen,Heo Jeong,Xie Qing,Zhang Mingxiang,Kim Yoon Jun,Lim Seng Gee,Fredrick Linda M,Lu Wenjing,Liu Wei,Kalluri Hari V,Krishnan Preethi,Tripathi Rakesh,Mobashery Niloufar,Burroughs Margaret,Asatryan Armen,Jia Jidong,Hou Jinlin

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference15 articles.

1. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes;Petruzziello;World J Gastroenterol,2016

2. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013;Stanaway;Lancet,2016

3. Hepatitis C virus genotypes and subtypes circulating in Mainland China;Chen;Emerg Microbes Infect,2017

4. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Lancet Gastroenterol Hepatol,2017

5. Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations;Soh;Singapore Med J,2019

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Data on the Use of Glecaprevir/Pibrentasvir in the Treatment of Hepatitis C: Is Shorter Treatment Possible?;Viral Hepatitis Journal;2024-08-28

2. Hepatitis C Virus: History and Current Knowledge;Gastroenterology Insights;2024-08-08

3. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients;JHEP Reports;2024-07

4. ‘Unusual’ HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment;Gut;2024-05-23

5. Identification of 2 Novel Subtypes of Hepatitis C Virus Genotype 8 and a Potential New Genotype Successfully Treated With Direct Acting Antivirals;The Journal of Infectious Diseases;2024-05-08